Origio A/S clinical trials

Acquired by CooperCompanies, 2012 · source ↗

The registry lists 2 studies whose lead sponsor is Origio A/S. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 15, 2015.

Before and after it joined CooperCompanies

First submitted before Origio A/S became part of CooperCompanies: 1
First submitted after Origio A/S became part of CooperCompanies: 0
Unclear, or no submission date: 1

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 1
Terminated: 1

Phase

Phase 3: 1

Where

United Kingdom: 1
Denmark: 1
Sweden: 1

Registry sponsor names on this page

Origio A/S2 studies

Something wrong with this grouping? Tell us on the CooperCompanies page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All CooperCompanies studies →

Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVFCompletedNCT00565747Phase 3
Sponsor listed in the registry: Origio A/S · First submitted before Origio A/S became part of CooperCompanies
Amino Acid Profiling of Spent Culture MediumTerminatedNCT01587547
Sponsor listed in the registry: Origio A/S · Unclear whether first submitted before or after Origio A/S became part of CooperCompanies